July 21, 2010

Another Coffin Nail for Avandia

The suspension follows the suspension of the TIDE trial in India, July 14, at the request of

Read More
Another Coffin Nail for Avandia

July 15, 2010

Will Another Blockbuster Drug Hit the Dust?

In 2007, an FDA advisory panel voted 22 to 1 to keep GlaxoSmithKline’s diabetes drug, Avandia (Rosiglitazone)

Read More
Will Another Blockbuster Drug Hit the Dust?

June 21, 2010

NIH Needs Sunshine Law Enforcement

CORRECTED/ REVISED This is a follow-up to our Infomail about the revelations in an investigative report by

Read More
NIH Needs Sunshine Law Enforcement

June 17, 2010

NIH Reform Compromised By Chief NIMH Psychiatrist

An investigative report by The Chronicle of Higher Education (June 6, 2010) provided details about the surrreptitious

Read More
NIH Reform Compromised By Chief NIMH Psychiatrist

June 13, 2010

Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks

A report in BNET, the business publication, by its pharmaceutical industry analyst, Jim Edwards, reveals that GlaxoSmithKline

Read More
Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks

February 22, 2010

Avandia Face-Off_GSK–Dr. Steven Nissen

The New York Times reports (below) that in May 2007, days before his Avandia safety study was

Read More
Avandia Face-Off_GSK–Dr. Steven Nissen

January 15, 2010

Antidepressants shown worthless for most consumers

After many years of controversy, the overwhelming evidence shows that psychiatrists and general practitioners have been misprescribing

Read More
Antidepressants shown worthless for most consumers

January 7, 2010

JAMA Antidepressant Meta-analysis Reveals 22 Years of Deception

Twenty-two years after the US marketing of Prozac, which changed the marketing, prescribing and widespread consumption of

Read More
JAMA Antidepressant Meta-analysis Reveals 22 Years of Deception

September 1, 2009

Ghostwritten reports corrupt science, undermine public health

Pharmaceutical companies are in business to sell their drugs at prices that will yield the highest profit.

Read More
Ghostwritten reports corrupt science, undermine public health

July 29, 2009

Pfizer-Neurontin Trial Testimony:”snake-oil list”

In 2004, Pfizer settled an illegal Neurontin marketing case with the U.S. Justice Department for $430 million. 

Read More
Pfizer-Neurontin Trial Testimony:”snake-oil list”

June 7, 2009

Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

FDA officials are ignoring the real world tragedies–drug-induced deaths of children. Unfortunately for the children, child psychiatrists

Read More
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

May 31, 2009

Antidepressants-Paxil, Prozac, Zoloft Increase Risk of Breast Cancer

An independent large study conducted by MEDCO Health Solutions Inc. found that women treated with tamoxifen for

Read More
Antidepressants-Paxil, Prozac, Zoloft Increase Risk of Breast Cancer

May 9, 2009

Texas Psychiatrist Karen Wagner Under Scrutiny

Citing Dr. Wagner’s failure to disclose $160,000 she received from GlaxoSmithKline, Sen. Charles Grassley has requested the

Read More
Texas Psychiatrist Karen Wagner Under Scrutiny

May 1, 2009

FDA-US Justice Dept. Withdraw Amicus Brief in Colacicco v. Apotex Inc,

Following the Supreme Court decision in Wyeth v Levine, denying Wyeth’s argument that FDA approval preempts state

Read More
FDA-US Justice Dept. Withdraw Amicus Brief in Colacicco v. Apotex Inc,